ATAP Files Comments with FTC
The Alliance for Transparent and Affordable Prescriptions (ATAP) is a coalition of patient and provider groups who are committed to reforming the role pharmacy benefit managers (PBMs) play in drug pricing and patient access. We thank the Federal Trade Commission (FTC) for the opportunity to provide comments on the topics raised in its Request for Information (RFI). Please click here for the comments filed on May 11, 2022:
We hope that our comments will encourage the FTC to undertake a comprehensive study of all aspects and dealings of the PBM industry, including its formulary design and utilization management practices. Furthermore, if the FTC conducts such a study, we urge the Commission to center the patient as the PBM’s customer, rather than the payer.